145 related articles for article (PubMed ID: 12488702)
21. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y
Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639
[TBL] [Abstract][Full Text] [Related]
22. [The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent].
Sładek M; Jedynak-Wasowicz U; Wedrychowicz A; Kowalska-Duplaga K; Pieczarkowski S; Fyderek K
Przegl Lek; 2007; 64 Suppl 3():65-7. PubMed ID: 18431918
[TBL] [Abstract][Full Text] [Related]
23. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection and inflammatory bowel disease: is there a link?
Papamichael K; Konstantopoulos P; Mantzaris GJ
World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359
[TBL] [Abstract][Full Text] [Related]
25. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study.
Duggan AE; Usmani I; Neal KR; Logan RF
Gut; 1998 Oct; 43(4):494-8. PubMed ID: 9824576
[TBL] [Abstract][Full Text] [Related]
26. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
[TBL] [Abstract][Full Text] [Related]
27. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of circulating platelet derived microparticles in Crohn's disease patients.
Tziatzios G; Polymeros D; Spathis A; Triantafyllou M; Gkolfakis P; Karakitsos P; Dimitriadis G; Triantafyllou K
Scand J Gastroenterol; 2016 Oct; 51(10):1184-92. PubMed ID: 27191369
[TBL] [Abstract][Full Text] [Related]
29. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
Bonapace CR; Mays DA
Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Cappello M; Licata A; Calvaruso V; Bravatà I; Aiello A; Torres D; Della Corte V; Tuttolomondo A; Perticone M; Licata G; Craxì A; Cammà C
Eur J Intern Med; 2017 Jan; 37():83-89. PubMed ID: 27773555
[TBL] [Abstract][Full Text] [Related]
31. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
32. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
33. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study.
Pilotto A; Leandro G; Di Mario F; Franceschi M; Bozzola L; Valerio G
Dig Dis Sci; 1997 Mar; 42(3):586-91. PubMed ID: 9073143
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease.
Bartels LE; Jepsen P; Christensen LA; Gerdes LU; Vilstrup H; Dahlerup JF
J Crohns Colitis; 2016 Apr; 10(4):443-8. PubMed ID: 26674958
[TBL] [Abstract][Full Text] [Related]
35. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease.
D'Incà R; Sturniolo G; Cassaro M; di Pace C; Longo G; Callegari I; Rugge M
Dig Dis Sci; 1998 May; 43(5):988-92. PubMed ID: 9590412
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.
Gisbert JP; Gomollón F; Maté J; Pajares JM
Dig Dis Sci; 2002 Mar; 47(3):471-88. PubMed ID: 11911332
[No Abstract] [Full Text] [Related]
39. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
40. Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.
Viazis N; Vlachogiannakos J; Georgiou O; Rodias M; Georgiadis D; Papastamopoulos V; Baraboutis IG; Karamanolis DG; Skoutelis A
Inflamm Bowel Dis; 2010 Mar; 16(3):507-11. PubMed ID: 19714759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
